Trial Profile
Effect of Rituximab given in combination with chemotherapy on chronic hepatitis C viremia in patients with non-Hodgkin's lymphomas
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2015
Price :
$35
*
At a glance
- Drugs Rituximab (Primary) ; Cyclophosphamide; Doxorubicin; Prednisolone; Vincristine
- Indications Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 28 Apr 2015 New trial record